DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ: A067080)
Health Care · Pharmaceuticals · KR
₩10,180.00
-4.86% today · -27.4% 1Y
DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ: A067080) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $128.67M.
Over the last twelve months the share price has lost 27.4%, trading between 7.46K and 24.90K.
Tweenvest scores DAE HWA Pharmaceutical Co., Ltd. across four factors: quality 52/100, value 53/100, growth 4/100, dividend 27/100. Its strongest factor is value.
A067080 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $128.67M
- Revenue (TTM)
- $96.06M
- P/E
- 41.06
- EPS
- 247.96
- Dividend yield
- 1.47%
- Beta (5Y)
- -0.16
- 52-week high
- ₩24,900.00
- 52-week low
- ₩7,460.00
- Avg volume (3M)
- —
- Shares outstanding
- 17.52M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,247.70 | +0.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.02 | -0.74% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $151.20 | +0.36% |
| Roche Holding AGSWX: ROP | $368.80B | CHF371.10 | +0.19% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.32 | +0.18% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.02 | +0.18% |
Figures last refreshed Aug 18, 2026.